Grassi, Fabio
Marino, Rebecca
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_192531)
Swiss-European Mobility Programme
Università della Svizzera italiana
Article History
Received: 17 January 2023
Accepted: 31 March 2023
First Online: 17 April 2023
Declarations
:
: FG is the Founder of MV BioTherapeutics, a biotech company developing biotherapeutics targeting extracellular ATP
: Not applicable.
: FG is the Founder of MV BioTherapeutics, a biotech company developing biotherapeutics targeting extracellular ATP